Form4insider filings, from the source

SEC Form 4 · accession 0001104659-26-070526

Keenova Therapeutics plc

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Scott Hirsch
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 4, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001567892

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Jun 2, 2026M2,685—A3,140D
Ordinary SharesF2Jun 2, 2026F619—D2,521D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F3,F4—Jun 2, 2026D2,197D——Ordinary Shares2,1976,669D
Restricted Stock UnitsF1,F4—Jun 2, 2026M2,685D——Ordinary Shares2,6853,984D

Explanation of responses

Remarks

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.